Skip to main content
Erschienen in: Obesity Surgery 9/2020

16.05.2020 | Original Contributions

Comparison of 2-Year Results of Roux-en-Y Gastric Bypass and Transit Bipartition with Sleeve Gastrectomy for Superobesity

verfasst von: Philippe Topart, Guillaume Becouarn, Jean-Baptiste Finel

Erschienen in: Obesity Surgery | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Although Roux-en-Y gastric bypass is a powerful procedure, achieving and maintaining significant weight loss remains challenging in superobese populations. Transit bipartition with sleeve gastrectomy is derived from biliopancreatic diversion with duodenal switch and might improve weight loss control.

Materials and Methods

Two series of 71 primary laparoscopic Roux-en-Y gastric bypass (RYGB) and transit bipartition (TB) with a body mass index ≥ 50 kg/m2 were retrospectively compared after 2 years. Postoperative course, side effects, nutritional status, and weight outcomes were reviewed. Weight was expressed as BMI, percentage of excess BMI lost (%EBMIL), and percentage of total weight lost (%TWL).

Results

The 2 groups were comparable for age and BMI of 51.9 ± 1.8 for RYGB and 51.6 ± 5 for TB. TB was longer to perform (92 vs 74 min, p ≤ 0.001) with a 30-day complication rate of 4.2% and 5.6%, but there was 1 death after RYGB. Weight loss was greater after TB compared with RYGB with %EBMIL of 85.3 ± 15.8% vs 73.9 ± 17.2% (p = 0.0002). One TB patient suffered from protein malnutrition but none after RYGB. After TB, 7% of the patients experienced > 3 stools a day and 1 patient required revision, while 3 patients had diarrhea after RYGB. Late reoperations were required for 7 and 1 patients after RYGB and TB. Comorbidity improvement was similar.

Conclusion

In a superobese population, TB appeared relatively safer compared with RYGB. It achieved a better weight loss at 2 years with a trend for more digestive side effects.
Literatur
1.
Zurück zum Zitat Santoro S, Malzoni CE, Velhote MC, et al. Digestive adaptation with intestinal reserve: a neuroendocrine-based operation for morbid obesity. Obes Surg. 2006;16:1371–9.CrossRef Santoro S, Malzoni CE, Velhote MC, et al. Digestive adaptation with intestinal reserve: a neuroendocrine-based operation for morbid obesity. Obes Surg. 2006;16:1371–9.CrossRef
2.
Zurück zum Zitat Topart P, Becouarn G, Finel JB. Is transit bipartition a better alternative to biliopancreatic diversion with duodenal switch for superobesity? Comparison of the early results of both procedures. Surg Obes Relat Dis. 2020;16:497–502.CrossRef Topart P, Becouarn G, Finel JB. Is transit bipartition a better alternative to biliopancreatic diversion with duodenal switch for superobesity? Comparison of the early results of both procedures. Surg Obes Relat Dis. 2020;16:497–502.CrossRef
3.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRef Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRef
4.
Zurück zum Zitat Santoro S, Castro LC, Velhote MC, et al. Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity. Ann Surg. 2012;256:104–10.CrossRef Santoro S, Castro LC, Velhote MC, et al. Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity. Ann Surg. 2012;256:104–10.CrossRef
5.
Zurück zum Zitat Yormaz S, Yılmaz H, Ece I, et al. Laparoscopic ileal interposition with diverted sleeve gastrectomy versus laparoscopic transit bipartition with sleeve gastrectomy for better glycemic outcomes in T2DM patients. Obes Surg. 2018;28:77–86.CrossRef Yormaz S, Yılmaz H, Ece I, et al. Laparoscopic ileal interposition with diverted sleeve gastrectomy versus laparoscopic transit bipartition with sleeve gastrectomy for better glycemic outcomes in T2DM patients. Obes Surg. 2018;28:77–86.CrossRef
6.
Zurück zum Zitat Biron S, Hould FS, Lebel S, et al. Twenty years of biliopancreatic diversion: what is the goal of the surgery? Obes Surg. 2004;14:160–4.CrossRef Biron S, Hould FS, Lebel S, et al. Twenty years of biliopancreatic diversion: what is the goal of the surgery? Obes Surg. 2004;14:160–4.CrossRef
7.
Zurück zum Zitat Christou NV, Look D, Maclean LD. Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006;244:734–40.CrossRef Christou NV, Look D, Maclean LD. Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006;244:734–40.CrossRef
8.
Zurück zum Zitat Dayan D, Kuriansky J, Abu-Abeid S. Weight regain following Roux-en-Y gastric bypass: etiology and surgical treatment. Isr Med Assoc J. 2019;12:823–8.PubMed Dayan D, Kuriansky J, Abu-Abeid S. Weight regain following Roux-en-Y gastric bypass: etiology and surgical treatment. Isr Med Assoc J. 2019;12:823–8.PubMed
9.
Zurück zum Zitat Obeid NR, Malick W, Concors SJ, et al. Long-term outcomes after Roux-en-Y gastric bypass: 10- to 13-year data. Surg Obes Relat Dis. 2016;12:11–20.CrossRef Obeid NR, Malick W, Concors SJ, et al. Long-term outcomes after Roux-en-Y gastric bypass: 10- to 13-year data. Surg Obes Relat Dis. 2016;12:11–20.CrossRef
10.
Zurück zum Zitat Shah K, Nergård BJ, Fagerland MW, et al. Limb length in gastric bypass in super-obese patients-importance of length of total alimentary small bowel tract. Obes Surg. 2019;29:2012–21.CrossRef Shah K, Nergård BJ, Fagerland MW, et al. Limb length in gastric bypass in super-obese patients-importance of length of total alimentary small bowel tract. Obes Surg. 2019;29:2012–21.CrossRef
11.
Zurück zum Zitat Bettencourt-Silva R, Neves JS, Pedro J, et al. Comparative effectiveness of different bariatric procedures in super morbid obesity. Obes Surg. 2019;29:281–91.CrossRef Bettencourt-Silva R, Neves JS, Pedro J, et al. Comparative effectiveness of different bariatric procedures in super morbid obesity. Obes Surg. 2019;29:281–91.CrossRef
12.
Zurück zum Zitat Moon RC, Nelson L, Teixeira AF, et al. Outcomes of Roux-en-Y gastric bypass in the super obese: comparison of body mass index 50-60 kg/m(2) and ≥60 kg/m(2) with the morbidly obese. Surg Obes Relat Dis. 2016;12:292–6.CrossRef Moon RC, Nelson L, Teixeira AF, et al. Outcomes of Roux-en-Y gastric bypass in the super obese: comparison of body mass index 50-60 kg/m(2) and ≥60 kg/m(2) with the morbidly obese. Surg Obes Relat Dis. 2016;12:292–6.CrossRef
13.
Zurück zum Zitat Parmar CD, Bryant C, Luque-de-Leon E, et al. One anastomosis gastric bypass in morbidly obese patients with BMI ≥ 50 kg/m(2): a systematic review comparing it with Roux-en-Y gastric bypass and sleeve gastrectomy. Obes Surg. 2019;29:3039–46.CrossRef Parmar CD, Bryant C, Luque-de-Leon E, et al. One anastomosis gastric bypass in morbidly obese patients with BMI ≥ 50 kg/m(2): a systematic review comparing it with Roux-en-Y gastric bypass and sleeve gastrectomy. Obes Surg. 2019;29:3039–46.CrossRef
14.
Zurück zum Zitat Sarhan M, Choi JJ, Al Sawwaf M, et al. Is weight loss better sustained with long-limb gastric bypass in the super-obese? Obes Surg. 2011;21:1337–43.CrossRef Sarhan M, Choi JJ, Al Sawwaf M, et al. Is weight loss better sustained with long-limb gastric bypass in the super-obese? Obes Surg. 2011;21:1337–43.CrossRef
15.
Zurück zum Zitat Jain D, Sill A, Averbach A. Do patients with higher baseline BMI have improved weight loss with Roux-en-Y gastric bypass versus sleeve gastrectomy? Surg Obes Relat Dis. 2018;14:1304–9.CrossRef Jain D, Sill A, Averbach A. Do patients with higher baseline BMI have improved weight loss with Roux-en-Y gastric bypass versus sleeve gastrectomy? Surg Obes Relat Dis. 2018;14:1304–9.CrossRef
16.
Zurück zum Zitat Prachand VN, Davee RT, Alverdy JC. Duodenal switch provides superior weightloss in the super-obese (BMI > or =50 kg/m2) compared with gastric bypass. AnnSurg. 2006;244:611–9. Prachand VN, Davee RT, Alverdy JC. Duodenal switch provides superior weightloss in the super-obese (BMI > or =50 kg/m2) compared with gastric bypass. AnnSurg. 2006;244:611–9.
17.
Zurück zum Zitat Risstad H, Søvik TT, Engström M, et al. Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial. JAMA Surg. 2015;150:352–61.CrossRef Risstad H, Søvik TT, Engström M, et al. Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial. JAMA Surg. 2015;150:352–61.CrossRef
18.
Zurück zum Zitat Hedberg J, Sundström J, Sundbom M. Duodenal switch versus Roux-en-Y gastric bypass for morbid obesity: systematic review and meta-analysis of weight results, diabetes resolution and early complications in single-centre comparisons. Obes Rev. 2014;15:555–63.CrossRef Hedberg J, Sundström J, Sundbom M. Duodenal switch versus Roux-en-Y gastric bypass for morbid obesity: systematic review and meta-analysis of weight results, diabetes resolution and early complications in single-centre comparisons. Obes Rev. 2014;15:555–63.CrossRef
19.
Zurück zum Zitat Skogar ML, Sundbom M. Weight loss and effect on co-morbidities in the long-term after duodenal switch and gastric bypass: a population-based cohort study. Surg Obes Relat Dis. 2020;16:17–23.CrossRef Skogar ML, Sundbom M. Weight loss and effect on co-morbidities in the long-term after duodenal switch and gastric bypass: a population-based cohort study. Surg Obes Relat Dis. 2020;16:17–23.CrossRef
20.
Zurück zum Zitat Topart P, Becouarn G, Ritz P. Weight loss is more sustained after biliopancreatic diversion with duodenal switch than Roux-en-Y gastric bypass in superobese patients. Surg Obes Relat Dis. 2013;9:526–30.CrossRef Topart P, Becouarn G, Ritz P. Weight loss is more sustained after biliopancreatic diversion with duodenal switch than Roux-en-Y gastric bypass in superobese patients. Surg Obes Relat Dis. 2013;9:526–30.CrossRef
21.
Zurück zum Zitat Cottam A, Cottam D, Zaveri H, et al. An analysis of mid-term complications, weight loss, and type 2 diabetes resolution of stomach intestinal pylorus-sparing surgery (SIPS) versus Roux-en-Y gastric bypass (RYGB) with three-year follow-up. Obes Surg. 2018;28:2894–902.CrossRef Cottam A, Cottam D, Zaveri H, et al. An analysis of mid-term complications, weight loss, and type 2 diabetes resolution of stomach intestinal pylorus-sparing surgery (SIPS) versus Roux-en-Y gastric bypass (RYGB) with three-year follow-up. Obes Surg. 2018;28:2894–902.CrossRef
22.
Zurück zum Zitat Lee WJ, Lee KT, Kasama K, et al. Laparoscopic single-anastomosis duodenal-jejunal bypass with sleeve gastrectomy (SADJB-SG): short-term result and comparison with gastric bypass. Obes Surg. 2014;24:109–13.CrossRef Lee WJ, Lee KT, Kasama K, et al. Laparoscopic single-anastomosis duodenal-jejunal bypass with sleeve gastrectomy (SADJB-SG): short-term result and comparison with gastric bypass. Obes Surg. 2014;24:109–13.CrossRef
23.
Zurück zum Zitat Nasser H, Ivanics T, Leonard-Murali S, et al. Perioperative outcomes of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy in super-obese and super-super-obese patients: a national database analysis. Surg Obes Relat Dis. 2019;15:1696–703.CrossRef Nasser H, Ivanics T, Leonard-Murali S, et al. Perioperative outcomes of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy in super-obese and super-super-obese patients: a national database analysis. Surg Obes Relat Dis. 2019;15:1696–703.CrossRef
24.
Zurück zum Zitat Celio AC, Wu Q, Kasten KR, et al. Comparative effectiveness of Roux-en-Y gastric bypass and sleeve gastrectomy in super obese patients. Surg Endosc. 2017;31:317–23.CrossRef Celio AC, Wu Q, Kasten KR, et al. Comparative effectiveness of Roux-en-Y gastric bypass and sleeve gastrectomy in super obese patients. Surg Endosc. 2017;31:317–23.CrossRef
25.
Zurück zum Zitat Sollier C, Barsamian C, Bretault M, et al. Diagnostic and therapeutic management of post-gastric bypass chronic diarrhea: a systematic review. Obes Surg. 2020;30:1102–11.CrossRef Sollier C, Barsamian C, Bretault M, et al. Diagnostic and therapeutic management of post-gastric bypass chronic diarrhea: a systematic review. Obes Surg. 2020;30:1102–11.CrossRef
Metadaten
Titel
Comparison of 2-Year Results of Roux-en-Y Gastric Bypass and Transit Bipartition with Sleeve Gastrectomy for Superobesity
verfasst von
Philippe Topart
Guillaume Becouarn
Jean-Baptiste Finel
Publikationsdatum
16.05.2020
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 9/2020
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04691-1

Weitere Artikel der Ausgabe 9/2020

Obesity Surgery 9/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.